These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 456403)

  • 21. Indobufen is a potent inhibitor of whole blood aggregation in patients with a high atherosclerotic risk.
    Mannucci L; Maderna P; Colli S; Lavezzari M; Sirtori CR; Tremoli E
    Thromb Res; 1987 Nov; 48(4):417-26. PubMed ID: 3445229
    [TBL] [Abstract][Full Text] [Related]  

  • 22. d-Indobufen inhibits collagen-induced intracellular calcium mobilization and inositol phosphates formation in human platelets.
    Sumi M; Hagiwara M; Hidaka H
    Thromb Res; 1990 Jul; 59(2):319-26. PubMed ID: 2237812
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacodynamic effects of indobufen compared with aspirin in patients with coronary atherosclerosis.
    Yang M; Ye Z; Mei L; Ullah I; Tan C; Wang G; Gu Q; Lu Y; Abdus S; Shi L; Gong X; Bai J; Eikelboom JW; Li C
    Eur J Clin Pharmacol; 2021 Dec; 77(12):1815-1823. PubMed ID: 34331551
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Evaluation of morning platelet aggregation in patients with ischemic cardiopathy after evening administration of indobufen].
    Craveri A; Lanfredini M; Citella C; Braconaro F; Colombo L
    Minerva Cardioangiol; 1988 Sep; 36(9):411-8. PubMed ID: 3226570
    [No Abstract]   [Full Text] [Related]  

  • 25. [Long-term effects of indobufen on several parameters of blood platelet function in subjects at thrombotic risk].
    Di Blasi S; Pintacuda S; Ferotti N; Lo Coco L; Muratore A; Russo G; Di Blasi U; D'Alessandro M; Morici G; Fornaciari M
    G Clin Med; 1990 Dec; 71(12):727-31. PubMed ID: 2150826
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A prostacyclin-sparing effect of indobufen vs. aspirin.
    De Caterina R; Giannessi D; Bernini W; Lazzerini G; Lavezzari M; Stragliotto E; Biagi G; Coccheri S
    Thromb Haemost; 1996 Mar; 75(3):510-4. PubMed ID: 8701417
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Activation and functions of blood platelets in patients with diabetes mellitus type 1 before and during the treatment with indobufen].
    Dmoszyńska-Giannopoulou A; Sokołowska B; Ledwozyw A
    Pol Arch Med Wewn; 1990 Mar; 83(3):97-103. PubMed ID: 2216938
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevention of in vivo platelet aggregation by indobufen in angina patients during exercise.
    Pogliani EM; Fantasia R; Perini C; Corvi G
    J Int Med Res; 1981; 9(2):113-9. PubMed ID: 7014283
    [No Abstract]   [Full Text] [Related]  

  • 29. Indobufen treatment in type IIA hypercholesterolemic subjects: effects on platelet function and malondialdehyde production.
    Tremoli E; Maderna P; Sirtori M; Colli S; Corvi G; Sirtori CR
    Pharmacol Res Commun; 1981 Oct; 13(9):847-59. PubMed ID: 7335762
    [No Abstract]   [Full Text] [Related]  

  • 30. Inhibition of thromboxane biosynthesis and platelet function by indobufen in type II diabetes mellitus.
    Davì G; Patrono C; Catalano I; Custro N; Giammarresi C; Ganci A; Cosentino F; Notarbartolo A
    Arterioscler Thromb; 1993 Sep; 13(9):1346-9. PubMed ID: 8364018
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical contribution to the study of indobufen, a new platelet aggregation inhibitor].
    Ciammaichella A; Luzi M; Pezzi F; Recchia O
    Clin Ter; 1982 Aug; 102(4):387-95. PubMed ID: 6754219
    [No Abstract]   [Full Text] [Related]  

  • 32. The d-enantiomer form of indobufen totally accounts for the anti-cyclooxygenase and antiplatelet activity ex vivo and for the increase in bleeding time by indobufen in man.
    De Caterina R; Sicari R; Yan A; Bernini W; Giannessi D; Lazzerini G; Efthymiopoulos C; Strolin-Benedetti M
    Thromb Haemost; 1992 Feb; 67(2):258-63. PubMed ID: 1621247
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiplatelet activity and tolerance of indobufen (K3920) in cerebrovascular disease: a therapeutic approach.
    Carrieri P; Orefice G; La Pia S; Indaco A; D'Acunio F; Iadevaia V
    Pharmatherapeutica; 1983; 3(6):410-6. PubMed ID: 6353432
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of ticlopidine and indobufen on platelet aggregation induced by A23187 and adrenaline in the presence of different anticoagulants.
    Cimminiello C; Milani M; Uberti T; Arpaia G; Bonfardeci G
    J Int Med Res; 1989; 17(6):514-20. PubMed ID: 2516825
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Excretion balance and urinary metabolism of indobufen in rats and mice.
    Grubb N; Caldwell J; Strolin-Benedetti M
    Biochem Pharmacol; 1993 Aug; 46(4):759-61. PubMed ID: 8363649
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of spontaneous platelet aggregation and adhesion by indobufen (K 3920). A randomized, double-blind crossover study on platelet, coagulation and fibrinolysis function tests.
    Nenci GG; Berrettini M; Iadevaia V; Parise P; Ballatori E
    Pharmatherapeutica; 1982; 3(3):188-94. PubMed ID: 7134226
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stereoselective pharmacokinetics of indobufen from tablets and intramuscular injections in man.
    Główka FK
    Chirality; 2000 Jan; 12(1):38-42. PubMed ID: 10602265
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term antiplatelet activity and safety of indobufen in patients with cardiovascular disease. Italian Multicenter Study Group.
    Int J Clin Pharmacol Ther Toxicol; 1985 Aug; 23(8):439-46. PubMed ID: 3899952
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Indobufen. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in cerebral, peripheral and coronary vascular disease.
    Wiseman LR; Fitton A; Buckley MM
    Drugs; 1992 Sep; 44(3):445-64. PubMed ID: 1382938
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antithrombotic effect of indobufen in an experimental model of arterio-arterial microanastomosis in the rat.
    Carrieri P; Donzelli R; Orefice G; Cerillo A; Volpentesta G; Tayana G
    Thromb Res; 1987 Feb; 45(3):195-9. PubMed ID: 3660337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.